Whilst BRCA1 and BRCA2 are considered “high risk” the other five members of this network component are considered “moderate risk” with a two- to fourfold increased breast cancer risk relative to the general population (10%) (Hollestelle et al., 2010). This evidence concerns the gene BRCA1 and breast cancer.